Literature DB >> 11905592

High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature.

A Tedeschi1, L Airaghi, S Giannini, L Ciceri, F M Massari.   

Abstract

A few reports have suggested the beneficial effect of high-dose intravenous immunoglobulin (IVIG) in the treatment of acute myocarditis and cardiomyopathy. We describe a 49-year-old woman in which acute myocarditis was diagnosed on the basis of clinical and echocardiographic findings. Conventional treatment with captopril and frusemide was administered: intravenous heparin and, subsequently, oral anticoagulants were added because of the appearance of an apical thrombus. On the fifth day of hospitalization, treatment with high-dose (400 mg kg(-1) day(-1)) IVIG was started and prosecuted for 5 days. A dramatic improvement of clinical conditions was observed, with increase of the left ventricular ejection fraction (LVEF) from 30% to 75% within 1 week. One year after the diagnosis the patient is in good health, with steady normal LVEF. The rapid recovery, which was immediately subsequent to the administration of high-dose IVIG, suggests that this kind of treatment has been effective in our patient with acute myocarditis.

Entities:  

Mesh:

Year:  2002        PMID: 11905592     DOI: 10.1046/j.1365-2796.2002.00929.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  14 in total

1.  Use of intravenous immunoglobulin in critically ill patients.

Authors:  Summer Donovan; Gonzalo M L Bearman
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

2.  Lethal influenza B myocarditis in a child and review of the literature for pediatric age groups.

Authors:  H Frank; C Wittekind; U G Liebert; M Siekmeyer; W Siekmeyer; V Schuster; W Kiess
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

Review 3.  Myocarditis.

Authors:  Sandeep Sagar; Peter P Liu; Leslie T Cooper
Journal:  Lancet       Date:  2011-12-18       Impact factor: 79.321

Review 4.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

5.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

Review 6.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

7.  Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature.

Authors:  Sorel Goland; Lawrence S C Czer; Robert J Siegel; Steven Tabak; Stanley Jordan; Daniel Luthringer; James Mirocha; Bernice Coleman; Robert M Kass; Alfredo Trento
Journal:  Can J Cardiol       Date:  2008-07       Impact factor: 5.223

Review 8.  Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review.

Authors:  Katya Meridor; Yehuda Shoenfeld; Oshrat Tayer-Shifman; Yair Levy
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

Review 9.  A systematic review of intravenous gamma globulin for therapy of acute myocarditis.

Authors:  Joan L Robinson; Lisa Hartling; Ellen Crumley; Ben Vandermeer; Terry P Klassen
Journal:  BMC Cardiovasc Disord       Date:  2005-06-02       Impact factor: 2.298

10.  Intravenous immunoglobulin for presumed viral myocarditis in children and adults.

Authors:  Joan Robinson; Lisa Hartling; Ben Vandermeer; Meghan Sebastianski; Terry P Klassen
Journal:  Cochrane Database Syst Rev       Date:  2020-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.